<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03394456</url>
  </required_header>
  <id_info>
    <org_study_id>K23DK110341</org_study_id>
    <secondary_id>K23DK110341</secondary_id>
    <secondary_id>H-40322</secondary_id>
    <nct_id>NCT03394456</nct_id>
  </id_info>
  <brief_title>Technology to Improve the Health of Resource-poor Hispanics With Diabetes</brief_title>
  <official_title>Technology to Improve the Health of Resource-poor Hispanics With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the efficacy and implementation of a telehealth-supported, integrated
      diabetes group visit program led by Community Health Workers (CHWs). PHASE ONE (N=89) relates
      to efficacy and PHASE TWO (N=37) addresses implementation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The number of Hispanics diagnosed with diabetes is escalating in the US with
      disproportionately higher prevalence and complication rates than other ethnicities. CHWs are
      a well-established and culturally sensitive means to bridge gaps in care to individuals with
      diabetes. However CHWs are often left unsupported, placing patients at risk of substandard
      care or harm. Telehealth is a term used to describe a range of technologies to support
      healthcare delivery via communication with the patient or a member of the healthcare delivery
      team. Though telehealth has been implemented into diabetes programs for many years, there is
      a paucity of data showing the use of telemedicine for CHW training and support. PHASE ONE of
      the current study compares clinical outcomes and treatment satisfaction of individuals who
      receive diabetes care in a 12-month telehealth supported, integrated CHW-led group visit
      program compared to those in usual care (wait list control). Group visits are 6-months and
      CHWs contact patients weekly to bimonthly (mobile health (mHealth)) for 12-months. This phase
      with have two cohort waves, separated by 6-months. The wait list control group for Cohort 2
      will explore telehealth, clinician-patient encounters. PHASE TWO occurs at a new clinic and
      evaluates the ability to implement the program in the first phase. This phase with have one
      cohort wave (Cohort 3), which follows the first phase. During both phases, CHWs receive
      training and support via telehealth and we will analyze its feasibility and acceptability.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 13, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>At baseline and every 6-months until study completion</time_frame>
    <description>Hemoglobin A1c (%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence to preventive care guidelines</measure>
    <time_frame>During six-month diabetes group visits</time_frame>
    <description>As measured by placement on a statin, annual urine micro albumin, target A1c, weight loss (if applicable), retinal eye examination, blood pressure targets, serum B12 measurements, vaccinations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survey</measure>
    <time_frame>at the beginning and end of each cohort (baseline, six-months)</time_frame>
    <description>The survey totaled 12 questions and assessed participant satisfaction, mental relaxation, and open-ended comments. Questions were ranked as followed: 1-3 (4-point Likert Scale), 4-7 (10-point Likert Scale), 8-11 (open-ended, descriptive), 12 (days of exercise/week). The Use of Mental Stress Management/Relaxation Techniques questionnaire and our pilot study survey templates were used to evaluate patient group visit and CHW satisfaction. We defined acceptability as high (3.5-4/4 or 8-10/10), moderate (2-3.4/4 or 4-7/10), and low (1-1.9/4 or 1-3/10) and totaled the items to create an overall score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes-related health</measure>
    <time_frame>at the beginning and end of each cohort (baseline, six-months)</time_frame>
    <description>As measured by the Self Management Resource Center Surveys: Diabetes Medications (a 4-question yes/no survey to assess patient medication adherence and understanding of their medications), Self-rated Health (a 1-question ranked on a 5-point scale (1 is excellent, 5 is poor) to determine the patient's view of their health)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>At baseline and every 6-month until study completion</time_frame>
    <description>Body Mass Index (BMI) (weight in kg/height in m^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>At baseline and every 6-month until study completion</time_frame>
    <description>Blood Pressure (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barriers to care</measure>
    <time_frame>weekly to bimonthly from baseline to 12-months</time_frame>
    <description>We obtain barriers to care data from the CHW-patient mobile health (mHealth) records and chart review, and group into three categories: obtaining medications, appointment access, clinic eligibility. mHealth records were sent to the study physician through a secure, encrypted site on a weekly basis.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Feasibility and acceptability of telehealth patient, clinician encounters during diabetes group visits</measure>
    <time_frame>At six months after group visits for wait list control Cohort 2</time_frame>
    <description>As measured by the Telehealth Usability Questionnaire(21-question survey where 1 is strongly disagree and 5 is strongly agree)</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility and acceptability of telehealth support for community health workers 2</measure>
    <time_frame>At baseline and six months during Cohort 1 intervention group</time_frame>
    <description>The Diabetes Knowledge Test (University of Michigan, 2015; 23 questions; where a total score of 0 indicates the least and 23 indicates the most diabetes knowledge based on this test)</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility and acceptability of telemedicine support for community health workers</measure>
    <time_frame>After each cohort (every six months)</time_frame>
    <description>As measured by a six-month 4-question survey (four open-ended questions i.e., what CHWs liked, disliked, general comments) and a 10-question multiple choice posttest that covers content they were taught the last six months (Vaughan et al, 2018)</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility and acceptability of telemedicine support for community health workers</measure>
    <time_frame>After Cohort 1</time_frame>
    <description>As measured by the Telehealth Usability Questionnaire(21-question survey where 1 is strongly disagree and 5 is strongly agree)</description>
  </other_outcome>
  <other_outcome>
    <measure>CHW knowledge</measure>
    <time_frame>During Cohort 2 at baseline (TEST-1 pretest), 6- (TEST-1 posttest, TEST-2 pretest) and 12-months (TEST-2 posttest)</time_frame>
    <description>As measured by two pre- and post-tests. TEST-1 (n=21 questions) and TEST-2 (n=19 questions). Tests were multiple choice with 3-5 answer option and were original to this study.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive diabetes group visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Receive usual care in the clinic, followed by group visits (wait list control)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diabetes program</intervention_name>
    <description>Comprehensive diabetes program (weekly to bimonthly CHW mHealth contact (phone, text) for 12-months and monthly diabetes group visits for 6-months)</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>telehealth training and support for Community Health Workers</intervention_name>
    <description>weekly 1-hour diabetes training and patient support for CHWs via telehealth i.e., ZOOM technology for the study duration</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hispanic adults with diabetes, low-income (earn less than/equal to 250% federal
             poverty level)

        Exclusion Criteria:

          -  not able to understand Spanish, group visit is not appropriate for care i.e., need
             individualized care, pregnancy, etc
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth Vaughan, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007 Oct;64(5 Suppl):101S-56S. Review.</citation>
    <PMID>17881626</PMID>
  </reference>
  <reference>
    <citation>Dias S, Gama A. [Community-based participatory research in public health: potentials and challenges]. Rev Panam Salud Publica. 2014 Feb;35(2):150-4. Portuguese.</citation>
    <PMID>24781097</PMID>
  </reference>
  <reference>
    <citation>Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lang T. The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial. Trials. 2011 Jun 9;12:145. doi: 10.1186/1745-6215-12-145.</citation>
    <PMID>21658262</PMID>
  </reference>
  <reference>
    <citation>Furino A. ï¿¼Community Health Worker National Workforce Study. Wasthington, DC: US Dept of Health and Human Services; 2007.</citation>
  </reference>
  <reference>
    <citation>Norris SL, Chowdhury FM, Van Le K, Horsley T, Brownstein JN, Zhang X, Jack L Jr, Satterfield DW. Effectiveness of community health workers in the care of persons with diabetes. Diabet Med. 2006 May;23(5):544-56. Review.</citation>
    <PMID>16681564</PMID>
  </reference>
  <reference>
    <citation>Lujan J, Ostwald SK, Ortiz M. Promotora diabetes intervention for Mexican Americans. Diabetes Educ. 2007 Jul-Aug;33(4):660-70.</citation>
    <PMID>17684167</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>December 21, 2017</study_first_submitted>
  <study_first_submitted_qc>January 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2018</study_first_posted>
  <last_update_submitted>November 5, 2019</last_update_submitted>
  <last_update_submitted_qc>November 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Elizabeth Vaughan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified patient data that underly study results as documented by the study protocol upon study completion and 12 months after article publication with researchers who provide a proposal to achieve the aim in their proposal directed to to study PI until 36 months after article publication.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>upon study completion</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

